Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- 1 The developmental origins of health and disease: an overview
- 2 The ‘developmental origins’ hypothesis: epidemiology
- 3 The conceptual basis for the developmental origins of health and disease
- 4 The periconceptional and embryonic period
- 5 Epigenetic mechanisms
- 6 A mitochondrial component of developmental programming
- 7 Role of exposure to environmental chemicals in developmental origins of health and disease
- 8 Maternal nutrition and fetal growth and development
- 9 Placental mechanisms and developmental origins of health and disease
- 10 Control of fetal metabolism: relevance to developmental origins of health and disease
- 11 Lipid metabolism: relevance to developmental origins of health and disease
- 12 Prenatal hypoxia: relevance to developmental origins of health and disease
- 13 The fetal hypothalamic–pituitary–adrenal axis: relevance to developmental origins of health and disease
- 14 Perinatal influences on the endocrine and metabolic axes during childhood
- 15 Patterns of growth: relevance to developmental origins of health and disease
- 16 The developmental environment and the endocrine pancreas
- 17 The developmental environment and insulin resistance
- 18 The developmental environment and the development of obesity
- 19 The developmental environment and its role in the metabolic syndrome
- 20 Programming the cardiovascular system
- 21 The role of vascular dysfunction in developmental origins of health and disease: evidence from human and animal studies
- 22 The developmental environment and atherogenesis
- 23 The developmental environment, renal function and disease
- 24 The developmental environment: effect on fluid and electrolyte homeostasis
- 25 The developmental environment: effects on lung structure and function
- 26 Developmental origins of asthma and related allergic disorders
- 27 The developmental environment: influences on subsequent cognitive function and behaviour
- 28 The developmental environment and the origins of neurological disorders
- 29 The developmental environment: clinical perspectives on effects on the musculoskeletal system
- 30 The developmental environment: experimental perspectives on skeletal development
- 31 The developmental environment and the early origins of cancer
- 32 The developmental environment: implications for ageing and life span
- 33 Developmental origins of health and disease: implications for primary intervention for cardiovascular and metabolic disease
- 34 Developmental origins of health and disease: public-health perspectives
- 35 Developmental origins of health and disease: implications for developing countries
- 36 Developmental origins of health and disease: ethical and social considerations
- 37 Past obstacles and future promise
- Index
- References
33 - Developmental origins of health and disease: implications for primary intervention for cardiovascular and metabolic disease
Published online by Cambridge University Press: 08 August 2009
Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- 1 The developmental origins of health and disease: an overview
- 2 The ‘developmental origins’ hypothesis: epidemiology
- 3 The conceptual basis for the developmental origins of health and disease
- 4 The periconceptional and embryonic period
- 5 Epigenetic mechanisms
- 6 A mitochondrial component of developmental programming
- 7 Role of exposure to environmental chemicals in developmental origins of health and disease
- 8 Maternal nutrition and fetal growth and development
- 9 Placental mechanisms and developmental origins of health and disease
- 10 Control of fetal metabolism: relevance to developmental origins of health and disease
- 11 Lipid metabolism: relevance to developmental origins of health and disease
- 12 Prenatal hypoxia: relevance to developmental origins of health and disease
- 13 The fetal hypothalamic–pituitary–adrenal axis: relevance to developmental origins of health and disease
- 14 Perinatal influences on the endocrine and metabolic axes during childhood
- 15 Patterns of growth: relevance to developmental origins of health and disease
- 16 The developmental environment and the endocrine pancreas
- 17 The developmental environment and insulin resistance
- 18 The developmental environment and the development of obesity
- 19 The developmental environment and its role in the metabolic syndrome
- 20 Programming the cardiovascular system
- 21 The role of vascular dysfunction in developmental origins of health and disease: evidence from human and animal studies
- 22 The developmental environment and atherogenesis
- 23 The developmental environment, renal function and disease
- 24 The developmental environment: effect on fluid and electrolyte homeostasis
- 25 The developmental environment: effects on lung structure and function
- 26 Developmental origins of asthma and related allergic disorders
- 27 The developmental environment: influences on subsequent cognitive function and behaviour
- 28 The developmental environment and the origins of neurological disorders
- 29 The developmental environment: clinical perspectives on effects on the musculoskeletal system
- 30 The developmental environment: experimental perspectives on skeletal development
- 31 The developmental environment and the early origins of cancer
- 32 The developmental environment: implications for ageing and life span
- 33 Developmental origins of health and disease: implications for primary intervention for cardiovascular and metabolic disease
- 34 Developmental origins of health and disease: public-health perspectives
- 35 Developmental origins of health and disease: implications for developing countries
- 36 Developmental origins of health and disease: ethical and social considerations
- 37 Past obstacles and future promise
- Index
- References
Summary
Introduction
The impact of the environment on our lives over the aeons has been a dominant force helping to shape our genome, and within it the encrypted forms and functions that characterise our species. Throughout most of our evolutionary history, the environment has posed its nutritional challenges within the rubric of malnutrition and infection, and the drive to establish and retain food security has so dominated our activities over these millennia that survival advantage has accrued to thrifty genomes and thrifty ‘phenomes’ (Neel 1999, Hales and Barker 2001). That we should now be threatened by agricultural surplus is perhaps poetic justice. Regardless, in establishing our mastery over nature, and extracting three square meals per day, every day, as well as essentially relieving ourselves of the requirement for muscular work to secure food or defend life, we have fallen prey to the asynchronous kinetics of biological adaptation and environmental change (Gluckman and Hanson 2004). We have simply not had enough evolutionary time to adapt successfully to the increasing availability of food and reduction in physical activity required for daily life that have taken place at an increasingly rapid pace over the past 300 years.
The invention of agriculture some 10,000 years ago enabled the emergence of modern civilisations by ensuring surplus, fostering labour specialisation and thus the eventual rise of the capitalist approach to economic growth (Diamond 1998). Consistent food supply for populations enabled escape from malnutrition and infection.
- Type
- Chapter
- Information
- Developmental Origins of Health and Disease , pp. 436 - 445Publisher: Cambridge University PressPrint publication year: 2006
References
American Heart Association (2003). Hypertension Primer: the Essentials of High Blood Pressure, 3rd edn. Baltimore, MD: Lippincott Williams and Wilkins.
, , and (2002). Fetal origins of adult disease: strength of effects and biological basis. Int. J. Epidemiol., 31, 1235–9.CrossRefGoogle ScholarPubMed
, , , and (1993). Glucocorticoid exposure in utero: a new model for adult hypertension. Lancet, 41, 339–41.CrossRefGoogle Scholar
and (2002). Prenatal programming of postnatal endocrine glucocorticoids. Reproduction, 124, 459–67.CrossRefGoogle ScholarPubMed
(1992). Abdominal obesity and the metabolic syndrome. Ann. Med., 24, 465–8.CrossRefGoogle ScholarPubMed
and (2000). The metabolic syndrome: a neuroendocrine disorder?Br. J. Nutr., 83 (Suppl. 1), S49–57.CrossRefGoogle ScholarPubMed
(1997). Heart Disease: a Texbook of Cardiovascular Medicine, 5th edn. Philadelphia, PA: Saunders.Google Scholar
and (1994). Congenital oligonephropathy and the etiology of adult hypertension and progressive injury. Am. J. Kidney Dis., 23, 171–5.CrossRefGoogle Scholar
(1998). Guns, Germs and Steel: a Short History of Everybody for the Last 13,000 Years. London: Vintage.Google Scholar
, , and (1998). An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep. Clin. Sci., 94, 149–55.CrossRefGoogle Scholar
(2002). Hypertension genetics, single nucleotide polymorphisms, and the common disease:common variant hypothesis. Hypertension, 39, 323–33.CrossRefGoogle ScholarPubMed
and (2004). The intergenerational effects of fetal programming: non-genomic mechanisms for the inheritance of low birth weight and cardiovascular risk. J. Epidemiol., 180, 1–16.Google ScholarPubMed
, , , and (2003). Early adiposity rebound in childhood and risk of type 2 diabetes in adult life. Diabetologia, 46, 190–4.CrossRefGoogle ScholarPubMed
, and (2004). PPARS and the complex journey to obesity. Nat. Med., 10, 1–7.CrossRefGoogle ScholarPubMed
(2003). Research into policy: hypertension and diabetes mellitus in the Caribbean. West Indian Med. J., 52, 164–9.Google ScholarPubMed
, and (1998). Glucocorticoids and the preparation for life after birth: are there long term consequences of the life insurance?Proc. Nutr. Soc., 57, 113–22.CrossRefGoogle ScholarPubMed
and (1994). An assessment of nutritional factors affecting the BMI of a population. Eur. J. Clin. Nutr., 48 (Suppl. 3) S90–7.Google ScholarPubMed
, , et al. (1996). A comparative study of hypertension prevalence, awareness, treatment and control rates in St. Lucia, Jamaica and Barbados. J. Hypertens., 14, 495–502.CrossRefGoogle Scholar
(2002). Urban sprawl and public health. Public Health Rep., 117, 201–17.CrossRefGoogle ScholarPubMed
and (2004). The developmental origins of the metabolic syndrome. Trends Endocrinol. Metab., 15, 183–7.CrossRefGoogle ScholarPubMed
(1998). Epidemiology of type 2 diabetes: risk factors. Diabetes Care, 21 (Suppl. 3) C3–6.CrossRefGoogle ScholarPubMed
and (2003b). For debate: fetal and early postnatal growth restriction lead to diabetes, the metabolic syndrome and renal failure. Diabetologia, 46, 1013–19.Google Scholar
, , and (2002). How the built environment affects physical activity: views from urban planning. Am. J. Prev. Med., 23, 64–73.CrossRefGoogle ScholarPubMed
and (2000). Pancreatic development and adult diabetes. Pediatr. Res., 48, 269–74.CrossRefGoogle ScholarPubMed
and (2002). Optimal diets for prevention of coronary heart disease. JAMA, 288, 2569–78.CrossRefGoogle ScholarPubMed
, and (2000). The role of size at birth and postnatal catch-up growth in determining systolic blood pressure: a systematic review of the literature. J. Hypertens., 18, 815–31.CrossRefGoogle ScholarPubMed
, , , and (1993). Determinants of Diabetes mellitus in Pima Indians. Diabetes Care, 16, 216–27.CrossRefGoogle ScholarPubMed
and (1994). Increased systolic pressure in adult rats induced by fetal exposure to maternal low protein diets. Clin. Sci., 86, 217–22.CrossRefGoogle ScholarPubMed
(2001). Fetal programming of cardiovascular function through exposure to maternal undernutrition. Proc. Nutr. Soc., 60, 505–13.CrossRefGoogle ScholarPubMed
, , , , and (1999). Intrauterine programming of hypertension: the role of the renin angiotensin system. Biochem. Soc. Trans., 27, 88–93.CrossRefGoogle ScholarPubMed
and (1996). Is blood pressure inversely related to birth weight? The strength of evidence from a systematic review of the literature. J. Hypertens., 14, 935–41.CrossRefGoogle ScholarPubMed
, , , and (1992). Early growth and abdominal fatness in adult life. J. Epidemiol. Comm. Health, 46, 184–6.CrossRefGoogle ScholarPubMed
, , and (1996). Programming of glucose tolerance in the rat: role of placental 11 beta-hydroxysteroid dehydrogenase. Diabetologia, 39, 1299–305.CrossRefGoogle Scholar
Lucas, A. (1991). The childhood environment and adult disease. In Programming by Early Nutrition in Man (ed. . and ). Chichester: Wiley, pp. 38–55.Google Scholar
, , et al. (1997). Relation between body mass index and body fat in black population samples from Nigeria, Jamaica and the United States. Am. J. Epidemiol., 145, 620–8.CrossRefGoogle ScholarPubMed
, and (2004). Prenatal programming of angiotensin 11 type 2 receptor expression in the rat. Br. J. Nutr., 91, 133–40.CrossRefGoogle Scholar
, , et al. (2003). Effectiveness and costs of interventions to lower blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet, 361, 717–25.CrossRefGoogle ScholarPubMed
, , , , and (2003). Is birth weight related to later glucose and insulin metabolism? A systematic review. Diabet. Med., 20, 339–48.CrossRefGoogle ScholarPubMed
(1994). Population differences in body composition in relation to body mass index. Eur. J. Clin. Nutr., 48 (Suppl. 3), S10–27.Google ScholarPubMed
, and (2000). Evidence of progressive deterioration of renal function in rats exposed to a maternal low protein diet in utero. Br. J. Nutr., 83, 79–85.Google Scholar
and (2000). Fetal, infant and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ. Health Perspect., 108 (Suppl. 3), 545–53.CrossRefGoogle ScholarPubMed
(1999). Programming of hepatic and peripheral insulin sensitivity by maternal protein restriction. Biochem. Soc. Trans., 27, 94–7.CrossRefGoogle ScholarPubMed
and (1999). The long term consequences of intrauterine protein malnutriton for glucose metabolism. Proc. Nutr. Soc., 58, 615–19.CrossRefGoogle Scholar
, , et al. (1999). A low protein diet alters the balance of islet cell replication and apoptosis in the fetal and neonatal rat and is associated with a reduced pancreatic expression of insulin-like growth factor 11. Endocrinology, 140, 4861–73.CrossRefGoogle Scholar
, , , , and (1984). Adiposity rebound in children: a simple marker for predicting obesity. Am. J. Clin. Nutr., 39, 129–35.CrossRefGoogle Scholar
(1998). Physiological programming of the fetus. Clin. Perinatol., 25, 939–62.CrossRefGoogle ScholarPubMed
(2004). Obesity as the core of the metabolic syndrome and the management of coronary disease. Curr. Med. Res. Opin., 20, 295–304.CrossRefGoogle Scholar
, , , , and (2003). Reduced nephron number in adult sheep hypertensive as a result of prenatal glucocorticoid treatment. J. Physiol., 549, 929–35.CrossRefGoogle ScholarPubMed
World Health Organization (2000). Obesity: Preventing and Managing the Global Epidemic. WHO Technical Report Series, 894. Geneva: World Health Organization.
World Health Organization (2002). Programming of Chronic Disease by Impaired Fetal Nutrition: Evidence and Implications for Policy and Intervention Strategies. WHO/NHD/02.3; WHO/NPH/02.1. Geneva: World Health Organization.
World Health Organization (2003). Diet, Nutrition and Prevention of Chronic Diseases: Report of the Joint WHO/FAO Expert Consultation. WHO Technical Report Series, 916. Geneva: World Health Organization.
- 3
- Cited by